The TLR pathway is activated in APS patients, in which peripheral mononuclear cells show a significant increase in the gene expression of TLR2 and TLR4 that mediate aPL-induced vascular abnormalities (25). Here, TLR2 is linked to autoimmune polyendocrinopathy.